{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:14:29Z","timestamp":1783084469198,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Liaoning Province Scientific Projects","award":["2013408001"],"award-info":[{"award-number":["2013408001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.suronc.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T01:49:38Z","timestamp":1558316978000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Yuhai","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib1","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.suronc.2019.05.009_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"The Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"issue":"9685","key":"10.1016\/j.suronc.2019.05.009_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.suronc.2019.05.009_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.suronc.2019.05.009_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mrgentox.2004.11.012","article-title":"Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians","volume":"581","author":"Gu","year":"2005","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"10.1016\/j.suronc.2019.05.009_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng.558","article-title":"A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer","volume":"42","author":"Kiemeney","year":"2010","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.suronc.2019.05.009_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2005.08.065","article-title":"Prognostic markers for bladder cancer: international Consensus Panel on bladder tumor markers","volume":"66","author":"Habuchi","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.suronc.2019.05.009_bib9","first-page":"237","article-title":"Histologic typing of urinary bladder tumors","author":"Mostofi","year":"1973","journal-title":"Int. Histol. Classif. Tumors"},{"key":"10.1016\/j.suronc.2019.05.009_bib10","series-title":"The World Health Organization\/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder","first-page":"1435","author":"Epstein J","year":"1999"},{"issue":"4","key":"10.1016\/j.suronc.2019.05.009_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2003.05.101","article-title":"Radical cystectomy for bladder cancer today\u2014a homogeneous series without neoadjuvant therapy","volume":"21","author":"Madersbacher","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2019.05.009_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1200\/JCO.1997.15.3.1022","article-title":"Bladder preservation by combined modality therapy for invasive bladder cancer","volume":"15","author":"Kachnic","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2019.05.009_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.suronc.2019.05.009_bib14","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1200\/JCO.2016.67.9761","article-title":"Safety and efficacy of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer","volume":"34","author":"Massard","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib15","first-page":"665","article-title":"Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis","volume":"18","author":"Dammann","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.suronc.2019.05.009_bib16","article-title":"Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation","author":"Li","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.suronc.2019.05.009_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41467-017-02786-5","article-title":"RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73","volume":"9","author":"Papaspyropoulos","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.suronc.2019.05.009_bib18","series-title":"Apoptosis in Cancer Therapy: Crossing the Threshold","first-page":"539","author":"Fisher","year":"1994"},{"issue":"9","key":"10.1016\/j.suronc.2019.05.009_bib19","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","article-title":"Dysregulation of apoptosis in cancer","volume":"17","author":"Reed","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2019.05.009_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.suronc.2019.05.009_bib21","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1101\/gad.813200","article-title":"The Rb\/E2F pathway: expanding roles and emerging paradigms","volume":"14","author":"Harbour","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.suronc.2019.05.009_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair"},{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2004.02.005","article-title":"p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer","volume":"93","author":"Roh","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2019.05.009_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160961","article-title":"miR-6734 up-regulates p21 gene expression and induces cell cycle arrest and apoptosis in colon cancer cells","volume":"11","author":"Kang","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.suronc.2019.05.009_bib25","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.suronc.2019.05.009_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Canc."},{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2014.05.006","article-title":"Radiation-enhanced cell migration\/invasion process: a review","volume":"92","author":"Moncharmont","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.suronc.2019.05.009_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-011-1499-x","article-title":"Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets","volume":"128","author":"Li","year":"2011","journal-title":"Breast Canc. Res. Treat."},{"issue":"5","key":"10.1016\/j.suronc.2019.05.009_bib29","first-page":"311","article-title":"Breast cancer metastasis","volume":"9","author":"Scully","year":"2012","journal-title":"Canc. Genom. - Proteom."},{"issue":"14","key":"10.1016\/j.suronc.2019.05.009_bib30","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1091\/mbc.e11-04-0306","article-title":"Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer","volume":"22","author":"Wendt","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.suronc.2019.05.009_bib31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1083\/jcb.200308162","article-title":"Autoregulation of E-cadherin expression by cadherin\u2013cadherin interactions","volume":"163","author":"Conacci-Sorrell","year":"2003","journal-title":"J. Cell Biol."},{"issue":"43","key":"10.1016\/j.suronc.2019.05.009_bib32","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1038\/onc.2017.185","article-title":"beta-catenin downregulates Dicer to promote ovarian cancer metastasis","volume":"36","author":"To","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.suronc.2019.05.009_bib33","doi-asserted-by":"crossref","first-page":"19244","DOI":"10.18632\/oncotarget.13706","article-title":"MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9","volume":"8","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.suronc.2019.05.009_bib34","first-page":"217","article-title":"Inhibition of PC3 human prostate cancer cell proliferation, invasion and migration by eicosapentaenoic acid and docosahexaenoic acid","volume":"7","author":"Oono","year":"2017","journal-title":"Mol. Clin. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740419300118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740419300118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:16:57Z","timestamp":1760757417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740419300118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S0960740419300118"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2019.05.009","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}